Search Results - "van Halm, V P"

Rheumatoid arthritis versus diabetes as a risk factor for cardiovascular disease: a cross-sectional study, the CARRE Investigation by van Halm, V P, Peters, M J L, Voskuyl, A E, Boers, M, Lems, W F, Visser, M, Stehouwer, C D A, Spijkerman, A M W, Dekker, J M, Nijpels, G, Heine, R J, Bouter, L M, Smulders, Y M, Dijkmans, B A C, Nurmohamed, M T

“…Patients with rheumatoid arthritis (RA) have an increased cardiovascular risk, but the magnitude of this risk is not known precisely. A study was undertaken to…”
Get more information

Does preoperative multidisciplinary team assessment of high-risk patients improve the safety and outcomes of patients undergoing surgery? by Kuiper, B I, Janssen, L M J, Versteeg, K S, Ten Tusscher, B L, van der Spoel, J I, Lubbers, W D, Kazemier, G, Loer, S A, Schober, P, van Halm, V P

“…International guidelines recommend preoperative multidisciplinary team (MDT) assessment for high-risk surgical patients. Preoperative MDT meetings can help to…”
Get full text

Increased progression of carotid intima media thickness in thyroid peroxidase antibodies-positive rheumatoid arthritis patients by Raterman, H G, Voskuyl, A E, Simsek, S, Schreurs, M W J, van Hoogstraten, I M W, Peters, M J L, van Halm, V P, Dijkmans, B A C, Lips, P, Lems, W F, Nurmohamed, M T

“…ObjectiveAutoimmune diseases such as rheumatoid arthritis (RA) and hypothyroidism tend to cluster, and this coexistence amplifies the elevated cardiovascular…”
Get full text

The effects of golimumab treatment on systolic and diastolic left ventricular function in ankylosing spondylitis by Heslinga, S C, Konings, T C, van der Horst-Bruinsma, I E, Kamp, O, van Halm, V P, de Bruin-Bon, Hacm, Peters, M J, Nurmohamed, M T

“…Diastolic left ventricular (LV) dysfunction appears more prevalent in ankylosing spondylitis (AS). The effects of tumor necrosis factor alpha (TNF-α) blocking…”
Get full text

Aortic root diameter is associated with HLA-B27: identifying the patient with ankylosing spondylitis at risk for aortic valve regurgitation by Baniaamam, M., Heslinga, S. C., Konings, T. C., Handoko, M. L., Kamp, O., van Halm, V. P., van der Horst-Bruinsma, I. E., Nurmohamed, M. T.

“…To assess the association between the aortic root diameter in HLA-B27 positive (+) and HLA-B27 negative (−) ankylosing spondylitis (AS) patients from the…”
Get full text

Lipids and inflammation: serial measurements of the lipid profile of blood donors who later developed rheumatoid arthritis by van Halm, V P, Nielen, M M J, Nurmohamed, M T, van Schaardenburg, D, Reesink, H W, Voskuyl, A E, Twisk, J W R, van de Stadt, R J, de Koning, M H M T, Habibuw, M R, van der Horst–Bruinsma, I E, Dijkmans, B A C

“…Background: Rheumatoid arthritis is characterised by inflammation and an increased cardiovascular risk. It was recently shown that active early rheumatoid…”
Get full text

Statin therapy might be beneficial for patients with ankylosing spondylitis by van Denderen, J C, Peters, M J L, van Halm, V P, van der Horst-Bruinsma, I E, Dijkmans, B A C, Nurmohamed, M T

“…[...]as AS is associated with an increased cardiovascular risk, 5 the use of statins might ultimately lead to reduction of this risk by two pathways: one…”
Get full text

Changes in lipid profile during infliximab and corticosteroid treatment in rheumatoid arthritis by Peters, M J L, Vis, M, van Halm, V P, Wolbink, G J, Voskuyl, A E, Lems, W F, Dijkmans, B A C, Twisk, J W R, de Koning, M H M T, van de Stadt, R J, Nurmohamed, M T

“…Objective: To evaluate the effects of infliximab and corticosteroid treatment on the lipid profile in patients with active rheumatoid arthritis (RA). Methods:…”
Get full text

Rheumatoid arthritis is associated with a high prevalence of hypothyroidism that amplifies its cardiovascular risk by Raterman, H G, van Halm, V P, Voskuyl, A E, Simsek, S, Dijkmans, B A C, Nurmohamed, M T

“…Rheumatoid arthritis (RA) patients have an increased risk of developing cardiovascular diseases (CVD). Other autoimmune diseases such as hypothyroidism are…”
Get more information

Increased disease activity is associated with a deteriorated lipid profile in patients with ankylosing spondylitis by van Halm, V P, van Denderen, J C, Peters, M J L, Twisk, J W R, van der Paardt, M, van der Horst-Bruinsma, I E, van de Stadt, R J, de Koning, M H M T, Dijkmans, B A C, Nurmohamed, M T

“…Background: Cardiovascular mortality is increased in patients with ankylosing spondylitis. A possible explanation might be a more prevalent atherogenic lipid…”
Get full text

Antibodies against human 60 kDa heat shock protein are not associated with cardiovascular disease in patients with rheumatoid arthritis by van Halm, V P, Slot, M C, Nurmohamed, M T, Cohen Tervaert, J W, Dijkmans, B A C, Voskuyl, A E

“…Background: Rheumatoid arthritis is associated with an unexplained increased risk of cardiovascular disease (CVD). Antibodies against human 60 kDa heat shock…”
Get full text

Atherosclerotic cardiovascular disease in patients with chronic inflammatory joint disorders by Agca, R, Heslinga, S C, van Halm, V P, Nurmohamed, M T

“…Inflammatory joint disorders (IJD), including rheumatoid arthritis (RA), ankylosing spondylitis (ASp) and psoriatic arthritis (PsA), are prevalent conditions…”
Get more information

Defibrillation threshold in elective subcutaneous implantable defibrillator generator replacements: Time to reduce the size of the pulse generator? by van der Stuijt, W., Pepplinkhuizen, S., de Veld, J.A., Quast, A.B.E., van Halm, V.P., Bijsterveld, N.R., Olde Nordkamp, L.R.A., Wilde, A.A.M., Smeding, L., Knops, R.E.

“…The first step-down defibrillation studies in the subcutaneous implantable cardioverter-defibrillator (S-ICD) described a defibrillation threshold (DFT) of…”
Get full text

In RA patients without prevalent CVD, incident CVD is mainly associated with traditional risk factors: A 20-year follow-up in the CARRÉ cohort study by Raadsen, R., Agca, R., Boers, M., van Halm, V.P., Peters, M.J.L., Smulders, Y., Beulens, J.W.J., Blom, M.T., Stehouwer, C.D.A., Voskuyl, A.E., Lems, W.F., Nurmohamed, M.T.

“…To extend our investigation of cardiovascular diseases (CVD) in rheumatoid arthritis (RA) patients to a follow up of more than 20 years, with a special focus…”
Get full text

Tumor necrosis factor blocking therapy and congestive heart failure in patients with inflammatory rheumatic disorders: a systematic review by Heslinga, S C, Van Sijl, A M, De Boer, K, Van Halm, V P, Nurmohamed, M T

“…Tumour necrosis factor (TNF) blocking therapy is an effective treatment for chronic inflammatory arthritis. As circulating TNF might induce or exacerbate the…”
Get more information

Subclinical renal dysfunction is independently associated with cardiovascular events in rheumatoid arthritis: the CARRÉ Study by van Sijl, A M, van den Oever, I A M, Peters, M J L, Boers, M, Dijkmans, B A C, van Halm, V P, Smulders, Y M, Voskuyl, A E, Nurmohamed, M T

“…Patients with rheumatoid arthritis (RA) have double the risk of cardiovascular (CV) disease, largely independently of traditional CV risk factors. Renal…”
Get more information

The metabolic syndrome is amplified in hypothyroid rheumatoid arthritis patients: a cross-sectional study by Raterman, H G, van Eijk, I C, Voskuyl, A E, Peters, M J L, Dijkmans, B A C, van Halm, V P, Simsek, S, Lems, W F, Nurmohamed, M T

“…Rheumatoid arthritis (RA) patients are at increased risk of cardiovascular disease (CVD), which is even more pronounced in hypothyroid RA patients. An…”
Get more information

Acute hemodynamic effects of biventricular pacing studied during cardiovascular magnetic resonance imaging: the PICARIA Trial by Hopman, L H G, Zweerink, A, Van Der Lingen, A C J, Mulder, M J, Robbers, L F H, Van Halm, V P, Van Rossum, A C, Gotte, M J W, Allaart, C P

“…Abstract Background Cardiac resynchronization therapy (CRT) is hampered by a relative high rate of non-response whereby device optimization could aid in…”
Get full text

Factors influencing inappropriate device therapy in implantable cardioverter defibrillators: a predictive analysis by Huntelaar, M J, Krabbenborg, J, Van Der Lingen, A C J, Hopman, L H G A, Rijnierse, M T, Kemme, M J B, Allaart, C P, Van Halm, V P

“…Abstract Background Implantable cardioverter defibrillator (ICD) implantation and subsequent ICD therapy have shown to be efficacious in the prevention of…”
Get full text

Impact of phase-correction of late-gadolinium enhancement images on quantification of scar metrics and in-silico VT-modelling in patients with an ischemic cardiomyopathy by Bhagirath, P, Campos, F O, Hopman, L, Kemme, M J B, Postema, P G, Prassl, A J, Neic, A, Robbers, L F H J, Gotte, M J W, Plank, G, Van Halm, V P, Bishop, M

“…Abstract Background Late gadolinium enhancement (LGE) is used to perform tissue characterization and has become the cornerstone to guide treatment of…”
Get full text